Although China has in the past decade been reluctant to grant patents on human embryonic stem cell technology, it has recently changed its patent policy to loosen some restrictions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Thomson, J.A. et al. Science 282, 1145–1147 (1998).
Bonetta, L. Cell 132, 514–516 (2008).
SIPO. Guidelines for Patent Examination, Part II, Chapter 10, Section 2.1. (Intellectual Property Publishing House, 2010).
Hansson, M.G., Helgesson, G., Wessman, R. & Jaenisch, R. Stem Cells 25, 1507–1510 (2007).
Patent Law of the People's Republic of China, Article 5, Paragraph 1.
WTO. Agreement on Trade-Related Aspects of Intellectual Property Rights, Marrakesh, Morocco (15 April 1994).
SIPO. Guidelines for Patent Examination, Part II, Chapter 1, Section 3.1.2, paragraph 1 (Intellectual Property Publishing House, 2010).
SIPO. Guidelines for Patent Examination, Part II, Chapter 1, Section 3.1.1, paragraph 1 (Intellectual Property Publishing House, 2010).
The Law Department of the SIPO. Explanation to the Newly-Adapted Patent Law. 27 (Intellectual Property Publishing House, 2001).
SIPO. Guidelines for Patent Examination, Part II, Chapter 10, Section 9.1.1.1, paragraph 1 (Intellectual Property Publishing House, 2010).
Department of Examination and Business Management of the SIPO. An Introduction to the Revision of Guidelines for Patent Examination 2006, Edn. 2, 220–221 (Intellectual Property Publishing House, 2006).
SIPO. Guidelines for Patent Examination, Part II, Chapter 10, Section 9.1.1.2, paragraph 1 (Intellectual Property Publishing House, 2010).
Edwards, R.G., Steptoe, P.C. & Purdy, J.M. BJOG 87, 737–756 (1980).
SIPO. Guidelines for Patent Examination, Part II, Chapter 1, Section 3.1.2, paragraph 1 (Intellectual Property Publishing House, 2010).
SIPO. Patent Reexamination Board, FS4237. (February 6, 2004).
Lipu, T. Chinese Intellectual Property Yearbook. 364 (Intellectual Property Publishing House, 2004).
SIPO. Patent Reexamination Board, FS17820. (July 2, 2009).
SIPO. Patent Reexamination Board, FS25050. (July 26, 2010).
SIPO. Patent Reexamination Board, FS46359. (October 24, 2012).
EPO Technical Board of Appeal 3.3.02. T19/90 (October 3, 1990).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Peng, Y. The patentability of human embryonic stem cell technology in China. Nat Biotechnol 34, 37–39 (2016). https://doi.org/10.1038/nbt.3417
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3417
